Patient Journey Guides

Medical Records for an MDS Consultation in China: Marrow Reports, Genetics, Transfusions and Treatment History

A diagnosis certificate and the latest blood count tell a receiving doctor that you have MDS. They rarely explain why transfusions have increased, whether a medicine has helped or what led to a transplant recommendation. For a useful consultation, the specialist needs to reconstruct the course of the illness from dated evidence.

Key takeaways

These excerpts come from the original article. Read the full sections below for context.

  • Include age, the main symptoms, when abnormal counts were first found, the diagnosis date and current treatment. State the question you want answered. “My transfusion interval has shortened; does my anemia treatment need reassessment?” is easier to address than a request for the best available medicine. If the reason for a change is unknown, say so.
  • For each medicine, give its generic name, route, start and stop dates, delivered dose, cycle information and the reason for a delay or reduction. Preserve both the planned prescription and administration record if they differ. A discharge sentence stating that one course was completed cannot substitute for the record of what was given.
  • An upload confirmation means the files arrived; it does not mean the hematologist has interpreted them. Ask which items are readable, what is missing and when a clinical response is expected. If a new report arrives during the waiting period, identify the addition and its date so the consultation is not based on an outdated package.

Quick answer

A diagnosis certificate and the latest blood count tell a receiving doctor that you have MDS. They rarely explain why transfusions have increased, whether a medicine has helped or what led to a transplant recommendation. For a useful consultation, the specialist needs to reconstruct the course of the illness from dated evidence.

Full guide

A diagnosis certificate and the latest blood count tell a receiving doctor that you have MDS. They rarely explain why transfusions have increased, whether a medicine has helped or what led to a transplant recommendation. For a useful consultation, the specialist needs to reconstruct the course of the illness from dated evidence.

Begin with a short summary and attach the original documents. Organize them under diagnosis, blood counts and transfusions, treatment, and infections or other illnesses. The summary points the reader toward important events; it does not replace the reports. The NCI discussion of second opinions recommends involving your current doctor so the relevant records are available. This checklist is for organizing information you already have, not an instruction to repeat every test.

Put the referral question on the first page

Include age, the main symptoms, when abnormal counts were first found, the diagnosis date and current treatment. State the question you want answered. “My transfusion interval has shortened; does my anemia treatment need reassessment?” is easier to address than a request for the best available medicine. If the reason for a change is unknown, say so.

List any WHO classification and IPSS-R or IPSS-M assessment exactly as documented, with the date and issuing service. Preserve different conclusions when hospitals disagree. The International Consensus Classification integrates morphological, clinical and genomic information. A translator or family member should not select a final diagnosis merely to make the records look consistent.

Identify the current hematology service and the person receiving correspondence. For a child, include pediatric follow-up and guardian details. For an older adult, a brief description of independent living, mobility and recent falls can give the specialist context that laboratory results do not provide. Keep the summary concise enough to read before opening the attachments.

Request the full marrow record

Save aspiration and biopsy reports separately, including specimen identifiers, dates and every page. The two procedures provide different information, as explained in the MedlinePlus guide to marrow tests. Supplying only one report may leave part of the original assessment out of view.

Attach additional reports such as flow cytometry, iron staining and immunohistochemistry when performed. Preserve the actual wording and numbers for blasts, cellularity, fibrosis and other findings. A phrase such as “severe marrow disease” should not replace the laboratory description. If an addendum revised the initial conclusion, keep both versions and clearly identify the final one.

For a pathology opinion, ask the receiving laboratory which material it needs before requesting a loan from the original service. This may include slides, blocks or digital pathology, depending on the clinical question and what is available. Record specimen numbers, quantities and return requirements. Confirm any transport arrangements with the laboratories and carrier; do not package fresh blood or marrow yourself for international shipping.

Keep cytogenetic and sequencing reports intact

The karyotype report should include the complete chromosome description and laboratory comments. A FISH report should identify what was tested. For NGS, include sample type, collection date, panel coverage, all reported variants and the laboratory interpretation. “No abnormality found” in one method should not be used as a summary of tests that were never performed.

If IPSS-M has been calculated, attach the reports used at that time. The IPSS-M publication describes the use of molecular information in risk assessment. You do not need to calculate the score yourself. Mark an untested or pending gene result as missing so the hematologist can judge the completeness of the information.

Include genetic counseling and germline testing documents if they already exist. A mutation reported in tumor sequencing does not automatically establish an inherited change in the family. Whether confirmation is required, and whether it affects a related donor, belongs in a discussion with hematology and genetics specialists. Relatives should not determine their own donor eligibility from an online gene description.

Align blood counts with transfusions

Arrange results chronologically, preserving hemoglobin, absolute neutrophil count, platelets and any other measures your team is following. Keep units and reference intervals. Reports from different laboratories may use different units; copying only the abnormality flags makes comparison difficult. If anyone converts units in a summary, retain the original value for checking.

For each transfusion, record the date, component, quantity and the unit used by the blood service. A bag is not a consistent measure across every country and product. Include available pre- and post-transfusion results. Keep previous reactions, known antibodies and special blood requirements prominent in the file. The MedlinePlus explanation of red-cell antibody screening describes why this information matters for compatibility.

The timeline helps avoid a misleading interpretation: a higher hemoglobin after a transfusion being attributed entirely to a medicine. Whether treatment has produced a meaningful response requires the clinician to consider support received and the observation period. Supply the evidence without labeling each course a success or failure on your own.

Describe the treatment actually delivered

For each medicine, give its generic name, route, start and stop dates, delivered dose, cycle information and the reason for a delay or reduction. Preserve both the planned prescription and administration record if they differ. A discharge sentence stating that one course was completed cannot substitute for the record of what was given.

Prior treatment can determine whether another option is appropriate. For example, the FDA approval notice for imetelstat describes eligibility involving previous ESA response and transfusion burden. Such details should remain in the history. This US regulatory information does not establish approval or supply in China.

List current antimicrobial medicines, iron chelation, anticoagulants, supplements and herbal products as well. Patients may not think of these as MDS treatment, but the receiving team needs them when reviewing possible interactions and organ function. Preparing a transfer of care is not a reason to stop medicines or remove items from the list without medical advice.

Add infection, comorbidity and transplant information

After a recent infection admission, include microbiology, susceptibility results when available, imaging reports, antimicrobial treatment and the condition at discharge. If chest imaging was performed, ask whether the receiving team needs the complete DICOM study. An MDS referral does not mean everyone needs PET/CT; new imaging should answer a specific clinical question.

Summarize heart, lung, kidney and liver problems, previous cancers and previous chemotherapy or radiation. Describe what happened during a suspected allergic reaction rather than writing only “multiple allergies.” Fever, significant breathing difficulty, active bleeding or altered awareness should be assessed urgently; organizing records must not delay emergency care.

If transplant assessment has begun, add HLA reports, donor-search progress and completed organ assessments. A previous transplant requires a separate summary covering transplant date, conditioning, cell source, chimerism and disease monitoring, graft-versus-host disease and current immunosuppression. The NMDP treatment-decision resource can help frame questions about risks and benefits, while the actual team determines the plan.

Check the translation against the original

Use unambiguous dates, such as year-month-day. Prefer generic medicine names. Preserve the distinction between suspected, not excluded, not detected and test unsuccessful. A shorter translation is not better if it removes uncertainty that matters to the diagnosis. Bone marrow should not be confused with spinal cord, and blasts should not be replaced with a generic reference to abnormal cells.

Scan full pages so names, specimen identifiers, laboratory methods and comments remain legible. Check that every page is present before combining documents. Ask the receiving service how it accepts large files rather than reducing imaging to screenshots. If a compressed or translated copy is supplied, keep an unchanged original available.

Agree with the patient who may help with communication and use the institution's accepted channel for medical information. A family-created summary is not blanket permission to forward the whole record to unrelated recipients. The NCI communication guidance supports discussing information preferences, bringing questions and keeping a record of the answers.

Confirm that the clinical team has reviewed the package

An upload confirmation means the files arrived; it does not mean the hematologist has interpreted them. Ask which items are readable, what is missing and when a clinical response is expected. If a new report arrives during the waiting period, identify the addition and its date so the consultation is not based on an outdated package.

For a China consultation, obtain separate RMB estimates for translation, pathology review, specimen processing and any proposed additional tests. The price of document intake cannot be assumed to cover later laboratory work. Ask the actual service about turnaround, including whether outside testing, cell culture or additional material could affect scheduling. No single fee or review time applies to every file.

The finished package should let the doctor find the evidence for the diagnosis, see how the illness changed, identify treatment actually received and locate the current concern. Families do not need to become laboratory specialists. A reliable chronology with traceable originals is the most useful contribution they can make before the appointment.

Sources

This checklist concerns existing records. The receiving clinician should decide whether missing information requires further testing.

Related guides